103 related articles for article (PubMed ID: 19721426)
1. Limited significance of iodomethylnorcholesterol uptake in adrenal visualization.
Tanemoto M
Kidney Int; 2009 Sep; 76(6):678; author reply 678-9. PubMed ID: 19721426
[No Abstract] [Full Text] [Related]
2. Seeking the invisible: I-131 NP-59 SPECT/CT for primary hyperaldosteronism.
Chen YC; Wei CK; Chen PF; Tzeng JE; Chuang TL; Wang YF
Kidney Int; 2009 Mar; 75(6):663. PubMed ID: 19247385
[No Abstract] [Full Text] [Related]
3. Adrenocortical SPECT using iodine-131 NP-59.
Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
[TBL] [Abstract][Full Text] [Related]
4. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. III. Comparative studies of baseline and dexamethasone suppression imaging in aldosteronism.
Nakajo M
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):380-8. PubMed ID: 7122228
[No Abstract] [Full Text] [Related]
5. Use of NP-59 SPECT/CT imaging in atypical primary aldosteronism.
Chen YC; Chiu JS; Tseng CE; Chen YC
QJM; 2014 Mar; 107(3):233-4. PubMed ID: 23674720
[No Abstract] [Full Text] [Related]
6. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
[TBL] [Abstract][Full Text] [Related]
7. [Scintigraphic exploration of the adrenal glands using I-131-6 beta iodomethyl-19-norcholesterol. A practical guide].
Kraimps JL; Bardet S; Nocaudie-Calzada M; Tabarin A; Wémeau JL
Ann Chir; 1999; 53(3):255-60. PubMed ID: 10339872
[No Abstract] [Full Text] [Related]
8. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
[No Abstract] [Full Text] [Related]
9. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
[No Abstract] [Full Text] [Related]
10. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
Gordon L; Levine JH; Mayfield RK; Buse MG
J Nucl Med; 1979 Aug; 20(8):897-8. PubMed ID: 541739
[No Abstract] [Full Text] [Related]
11. Visualization of abnormal adrenal uptake of 19-iodocholesterol in Conn's.
Thomson DM; Dovey P; Davis JB
Br J Radiol; 1978 Jul; 51(607):545-6. PubMed ID: 352472
[No Abstract] [Full Text] [Related]
12. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism?
Spyridonidis TJ; Apostolopoulos DJ
Hell J Nucl Med; 2013; 16(2):134-9. PubMed ID: 23865085
[TBL] [Abstract][Full Text] [Related]
13. [Adrenal scanning with 131I cholesterol in primary hyperaldosteronism].
Neeman A; Traub J; Lubin A; Avidor E; Servadio C; Pinkhas J
Harefuah; 1978 Jan; 94(1):19-20. PubMed ID: 640498
[No Abstract] [Full Text] [Related]
14. Radiation dosimetry of adrenal imaging agents 19-iodocholesterol and 6-iodomethylnorcholesterol.
Brookeman VA
Int J Appl Radiat Isot; 1978 May; 29(4-5):277-9. PubMed ID: 689751
[No Abstract] [Full Text] [Related]
15. Adrenal scintigraphy in primary aldosteronism. Improved visualization after long-term pre-treatment with dexamethasone.
Hoefnagels WH; Claessens RA; Corstens FH; Drayer JI; Kazem I; Kloppenborg PW
Nuklearmedizin; 1981 Apr; 20(2):76-81. PubMed ID: 7243603
[TBL] [Abstract][Full Text] [Related]
16. Failure to visualize bilateral adrenal glands in a patient with primary aldosteronism.
Seino M; Abe K; Imai Y; Murakami O; Kasai Y; Sasaki S; Minami N; Munakata M; Kanazawa M; Takeuchi K
Clin Exp Hypertens A; 1990; 12(1):37-46. PubMed ID: 2155075
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of SPECT in adrenal imaging with iodine-131 6 beta-iodomethyl-19-norcholesterol.
Ishimura J; Kawanaka M; Fukuchi M
Clin Nucl Med; 1989 Apr; 14(4):278-81. PubMed ID: 2785015
[TBL] [Abstract][Full Text] [Related]
18. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
Freitas JE; Grekin RJ; Thrall JH; Gross MD; Swanson DP; Beierwaltes WH
J Nucl Med; 1979 Jan; 20(1):7-10. PubMed ID: 430181
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of adrenal scintigraphy and computed tomography (author's transl)].
Ishimaru J; Nishikawa J; Tasaka A; Machida K
Rinsho Hoshasen; 1981 May; 26(5):575-81. PubMed ID: 7277759
[No Abstract] [Full Text] [Related]
20. The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism.
Gross MD; Shapiro B; Grekin RJ; Meyers L; Swanson DP; Beierwaltes WH
J Clin Endocrinol Metab; 1983 Sep; 57(3):477-81. PubMed ID: 6874887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]